Живи долго! Научный подход к долгой молодости и здоровью

873

Sutter NB, Bustamante CD, Chase K, et al. A single IGF1 allele is a major determinant of small size in dogs. Science. 2007;316(5821):112–5. https://pubmed.ncbi.nlm.nih.gov/17412960/

874

Samaras TT. How height is related to our health and longevity: a review. Nutr Health. 2012;21(4):247–61. https://pubmed.ncbi.nlm.nih.gov/24620006/

875

Sohn K. Now, the taller die earlier: the curse of cancer. J Gerontol A Biol Sci Med Sci. 2016;71(6):713–9. https://pubmed.ncbi.nlm.nih.gov/25991828/

876

Samaras TT. How height is related to our health and longevity: a review. Nutr Health. 2012;21(4):247–61. https://pubmed.ncbi.nlm.nih.gov/24620006/

877

Samaras TT, Elrick H, Storms LH. Is height related to longevity? Life Sci. 2003;72(16):1781–802. https://pubmed.ncbi.nlm.nih.gov/12586217/

878

Samaras TT. How height is related to our health and longevity: a review. Nutr Health. 2012;21(4):247–61. https://pubmed.ncbi.nlm.nih.gov/24620006/

879

Один дюйм равен 2,54 см. – Примеч. ред.

880

Sohn K. Now, the taller die earlier: the curse of cancer. J Gerontol A Biol Sci Med Sci. 2016;71(6):713–9. https://pubmed.ncbi.nlm.nih.gov/25991828/

881

Walter RB, Brasky TM, Buckley SA, Potter JD, White E. Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst. 2013;105(12):860–8. https://pubmed.ncbi.nlm.nih.gov/23708052/

882

Shors AR, Solomon C, McTiernan A, White E. Melanoma risk in relation to height, weight, and exercise (United States). Cancer Causes Control. 2001;12(7):599–606. https://pubmed.ncbi.nlm.nih.gov/11552707/

883

Walter RB, Brasky TM, Buckley SA, Potter JD, White E. Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst. 2013;105(12):860–8. https://pubmed.ncbi.nlm.nih.gov/23708052/

884

Suh Y, Atzmon G, Cho MO, et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci U S A. 2008;105(9):3438–42. https://pubmed.ncbi.nlm.nih.gov/18316725/

885

Reed JC. Dysregulation of apoptosis in cancer. J Clin Oncol. 1999;17(9):2941–53. https://pubmed.ncbi.nlm.nih.gov/10561374/

886

Murphy N, Knuppel A, Papadimitriou N, et al. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, and breast cancer risk: observational and Mendelian randomization analyses with ~430 000 women. Ann Oncol. 2020;31(5):641–9. https://pubmed.ncbi.nlm.nih.gov/32169310/

887

Chi F, Wu R, Zeng Y, Xing R, Liu Y. Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysis. Mol Biol Rep. 2013;40(5):3583–90. https://pubmed.ncbi.nlm.nih.gov/23269623/

888

Travis RC, Appleby PN, Martin RM, et al. A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk. Cancer Res. 2016;76(8):2288–300. https://pubmed.ncbi.nlm.nih.gov/26921328/

889

Cao H, Wang G, Meng L, et al. Association between circulating levels of IGF-1 and IGFBP-3 and lung cancer risk: a meta-analysis. PLoS One. 2012;7(11):e49884. https://pubmed.ncbi.nlm.nih.gov/23185474/

890

Li Y, Li Y, Zhang J, et al. Circulating insulin-like growth factor-1 level and ovarian cancer risk. Cell Physiol Biochem. 2016;38(2):589–97. https://pubmed.ncbi.nlm.nih.gov/26845340/

891

Gong Y, Zhang B, Liao Y, et al. Serum insulin-like growth factor axis and the risk of pancreatic cancer: systematic review and meta-analysis. Nutrients. 2017;9(4):394. https://pubmed.ncbi.nlm.nih.gov/28420208/

892

Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor I and risk of breast cancer. Lancet. 1998;351(9113):1393–6. https://pubmed.ncbi.nlm.nih.gov/9593409/

893

Yee D. Insulin-like growth factor receptor inhibitors: baby or the bathwater? J Natl Cancer Inst. 2012;104(13):975–81. https://pubmed.ncbi.nlm.nih.gov/22761272/

894

Quan H, Tang H, Fang L, Bi J, Liu Y, Li H. IGF1(CA)19 and IGFBP-3–202A/C gene polymorphism and cancer risk: a meta-analysis. Cell Biochem Biophys. 2014;69(1):169–78. https://pubmed.ncbi.nlm.nih.gov/24310658/

895

Yokoyama NN, Denmon AP, Uchio EM, Jordan M, Mercola D, Zi X. When anti-aging studies meet cancer chemoprevention: can anti-aging agent kill two birds with one blow? Curr Pharmacol Rep. 2015;1(6):420–33. https://pubmed.ncbi.nlm.nih.gov/26756023/

896

Elia I, Doglioni G, Fendt SM. Metabolic hallmarks of metastasis formation. Trends Cell Biol. 2018;28(8):673–84. https://pubmed.ncbi.nlm.nih.gov/29747903/

897

Kleinberg DL, Wood TL, Furth PA, Lee AV. Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. Endocr Rev. 2009;30(1):51–74. https://pubmed.ncbi.nlm.nih.gov/19075184/

898

Yang SY, Miah A, Pabari A, Winslet M. Growth factors and their receptors in cancer metastases. Front Biosci (Landmark Ed). 2011;16:531–8. https://pubmed.ncbi.nlm.nih.gov/21196186/

899

Zhang Y, Ma B, Fan Q. Mechanisms of breast cancer bone metastasis. Cancer Lett. 2010;292(1):1–7. https://pubmed.ncbi.nlm.nih.gov/20006425/

900

Yang SY, Miah A, Pabari A, Winslet M. Growth factors and their receptors in cancer metastases. Front Biosci (Landmark Ed). 2011;16:531–8. https://pubmed.ncbi.nlm.nih.gov/21196186/

901

Sohn K. Now, the taller die earlier: the curse of cancer. J Gerontol A Biol Sci Med Sci. 2016;71(6):713–19. https://pubmed.ncbi.nlm.nih.gov/25991828/

902

Salvioli S, Capri M, Bucci L, et al. Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53. Cancer Immunol Immunother. 2009;58(12):1909–17. https://pubmed.ncbi.nlm.nih.gov/19139887/

903

Piantanelli L. Cancer and aging: from the kinetics of biological parameters to the kinetics of cancer incidence and mortality. Ann N Y Acad Sci. 1988;521:99–109. https://pubmed.ncbi.nlm.nih.gov/3377369/

904

Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell. 2005;120(4):449–60. https://pubmed.ncbi.nlm.nih.gov/15734678/

905

Stanta G, Campagner L, Cavallieri F, Giarelli L. Cancer of the oldest old. What we have learned from autopsy studies. Clin Geriatr Med. 1997;13(1):55–68. https://pubmed.ncbi.nlm.nih.gov/8995100/

906

Salvioli S, Capri M, Bucci L, et al. Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53. Cancer Immunol Immunother. 2009;58(12):1909–17. https://pubmed.ncbi.nlm.nih.gov/19139887/

907

Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone: a new inborn error of metabolism? Isr J Med Sci 1966;2:152–5. https://pubmed.ncbi.nlm.nih.gov/5916640/

908

Guevara-Aguirre J, Bautista C, Torres C, et al. Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador. Rev Endocr Metab Disord. 2021;22(1):59–70. https://pubmed.ncbi.nlm.nih.gov/33047268/

909

Laron Z, Kauli R, Lapkina L, Werner H. IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome. Mutat Res Rev Mutat Res. 2017;772:123–33. https://pubmed.ncbi.nlm.nih.gov/28528685/

910

Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011;3(70):70ra13. https://pubmed.ncbi.nlm.nih.gov/21325617/

911

Boguszewski CL, Boguszewski MC da S. Growth hormone’s links to cancer. Endocr Rev. 2019;40(2):558–74. https://pubmed.ncbi.nlm.nih.gov/30500870/

912

Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, et al. Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med. 2011;3(70):70ra13. https://pubmed.ncbi.nlm.nih.gov/21325617/

913

Laron Z, Kauli R, Lapkina L, Werner H. IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome. Mutat Res Rev Mutat Res. 2017;772:123–33. https://pubmed.ncbi.nlm.nih.gov/28528685/

914

Ma H, Zhang T, Shen H, Cao H, Du J. The adverse events profile of anti-IGF-1R monoclonal antibodies in cancer therapy. Br J Clin Pharmacol. 2014;77(6):917–28. https://pubmed.ncbi.nlm.nih.gov/24033707/

915

Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev. 1994;15(1):80–101. https://pubmed.ncbi.nlm.nih.gov/8156941/

916

Lee C, Safdie FM, Raffaghello L, et al. Reduced levels of IGF-I mediate differential protection of normal and cancer cells in response to fasting and improve chemotherapeutic index. Cancer Res. 2010;70(4):1564–72. https://pubmed.ncbi.nlm.nih.gov/20145127/

917

Longo VD, Anderson RM. Nutrition, longevity and disease: from molecular mechanisms to interventions. Cell. 2022;185(9):1455–70. https://pubmed.ncbi.nlm.nih.gov/35487190/

918

Dunn SE, Kari FW, French J, et al. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res. 1997;57(21):4667–72. https://pubmed.ncbi.nlm.nih.gov/9354418/

919

Fontana L, Weiss EP, Villareal DT, Klein S, Holloszy JO. Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell. 2008;7(5):681–7. https://pubmed.ncbi.nlm.nih.gov/18843793/

920

Schüler R, Markova M, Osterhoff MA, et al. Similar dietary regulation of IGF-1-and IGF-binding proteins by animal and plant protein in subjects with type 2 diabetes. Eur J Nutr. https://link.springer.com/article/10.1007/s00394–021–02518-y. Published online March 8, 2021. Accessed June 23, 2021.; https://pubmed.ncbi.nlm.nih.gov/33686453/

921

Allen NE, Appleby PN, Davey GK, Key TJ. Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men. Br J Cancer. 2000;83(1):95–7. https://pubmed.ncbi.nlm.nih.gov/10883675/

922

Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S, Key TJ. The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev. 2002;11(11):1441–8. https://pubmed.ncbi.nlm.nih.gov/12433724/

923

Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, Aronson WJ. Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control. 2002;13(10):929–35. https://pubmed.ncbi.nlm.nih.gov/12588089/

924

Flood A, Mai V, Pfeiffer R, et al. The effects of a high-fruit and – vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3. Eur J Clin Nutr. 2008;62(2):186–96. https://pubmed.ncbi.nlm.nih.gov/17487212/

925

Allen NE, Appleby PN, Davey GK, Key TJ. Hormones and diet: low insulin-like growth factor-I but normal bioavailable androgens in vegan men. Br J Cancer. 2000;83(1):95–7. https://pubmed.ncbi.nlm.nih.gov/10883675/

926

Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S, Key TJ. The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev. 2002;11(11):1441–8. https://pubmed.ncbi.nlm.nih.gov/12433724/

927

Berrino F, Bellati C, Secreto G, et al. Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev. 2001;10(1):25–33. https://pubmed.ncbi.nlm.nih.gov/11205485/

928

Kaaks R, Bellati C, Venturelli E, et al. Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised Trial. Eur J Clin Nutr. 2003;57(9):1079–88. https://pubmed.ncbi.nlm.nih.gov/12947426/

929

Pasanisi P, Bruno E, Venturelli E, et al. A dietary intervention to lower serum levels of IGF-I in BRCA mutation carriers. Cancers (Basel). 2018;10(9):309. https://pubmed.ncbi.nlm.nih.gov/30181513/

930

Gulick CN, Peddie MC, Cameron C, Bradbury K, Rehrer NJ. Physical activity, dietary protein and insulin-like growth factor 1: cross-sectional analysis utilising UK Biobank. Growth Horm IGF Res. 2020;55:101353. https://pubmed.ncbi.nlm.nih.gov/33002777/

931

Toden S, Belobrajdic DP, Bird AR, Topping DL, Conlon MA. Effects of dietary beef and chicken with and without high amylose maize starch on blood malondialdehyde, interleukins, IGF-I, insulin, leptin, MMP-2, and TIMP-2 concentrations in rats. Nutr Cancer. 2010;62(4):454–65. https://pubmed.ncbi.nlm.nih.gov/20432166/

932

Qin LQ, He K, Xu JY. Milk consumption and circulating insulin-like growth factor-I level: a systematic literature review. Int J Food Sci Nutr. 2009;60(S7):330–40. https://pubmed.ncbi.nlm.nih.gov/19746296/

933

Один галлон равен 4,55 л. – Примеч. ред.

934

Hoppe C, Kristensen M, Boiesen M, Kudsk J, Michaelsen KF, Mølgaard C. Short-term effects of replacing milk with cola beverages on insulin-like growth factor-I and insulin – glucose metabolism: a 10 d interventional study in young men. Br J Nutr. 2009;102(7):1047–51. https://pubmed.ncbi.nlm.nih.gov/15578035/

935

Harrison S, Lennon R, Holly J, et al. Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis. Cancer Causes Control. 2017;28(6):497–528. https://pubmed.ncbi.nlm.nih.gov/28361446/

936

Adams AM, Smith AF. Risk perception and communication: recent developments and implications for anaesthesia. Anaesthesia. 2001;56(8):745–55. https://pubmed.ncbi.nlm.nih.gov/11493237/

937

Harrison S, Lennon R, Holly J, et al. Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis. Cancer Causes Control. 2017;28(6):497–528. https://pubmed.ncbi.nlm.nih.gov/28361446/

938

Naghshi S, Sadeghi O, Larijani B, Esmaillzadeh A. High vs. low-fat dairy and milk differently affects the risk of all-cause, CVD, and cancer death: a systematic review and dose-response meta-analysis of prospective cohort studies. Crit Rev Food Sci Nutr. 2021;Jan 5:1–15. https://pubmed.ncbi.nlm.nih.gov/33397132/

939

Qin LQ, He K, Xu JY. Milk consumption and circulating insulin-like growth factor-I level: a systematic literature review. Int J Food Sci Nutr. 2009;60(7):330–40. https://pubmed.ncbi.nlm.nih.gov/19746296/

940

Jones CM, Heinrichs J. Growth charts for dairy heifers. Penn State Extension. https://extension.psu.edu/growth-charts-for-dairy-heifers. Updated July 28, 2017. Accessed June 9, 2021.; https://extension.psu.edu/growth-charts-for-dairy-heifers

941

Clatici VG, Voicu C, Voaides C, Roseanu A, Icriverzi M, Jurcoane S. Diseases of civilization – cancer, diabetes, obesity and acne – the implication of milk, IGF-1 and mTORC1. Maedica (Bucur). 2018;13(4):273–81. https://pubmed.ncbi.nlm.nih.gov/30774725/

942

Honegger A, Humbel RE. Insulin-like growth factors I and II in fetal and adult bovine serum. Purification, primary structures, and immunological cross-reactivities. J Biol Chem. 1986;261(2):569–75. https://pubmed.ncbi.nlm.nih.gov/3941093/

943

Collier RJ, Miller MA, Hildebrandt JR, et al. Factors affecting insulin-like growth factor-I concentration in bovine milk. J Dairy Sci. 1991;74(9):2905–11. https://pubmed.ncbi.nlm.nih.gov/1779049/

944

Kim WK, Ryu YH, Seo DS, Lee CY, Ko Y. Effects of oral administration of insulin-like growth factor-I on circulating concentration of insulin-like growth factor-I and growth of internal organs in weanling mice. Biol Neonate. 2006;89(3):199–204. https://pubmed.ncbi.nlm.nih.gov/16293962/

945

Clatici VG, Voicu C, Voaides C, Roseanu A, Icriverzi M, Jurcoane S. Diseases of civilization – cancer, diabetes, obesity and acne – the implication of milk, IGF-1 and mTORC1. Maedica (Bucur). 2018;13(4):273–81. https://pubmed.ncbi.nlm.nih.gov/30774725/

946

Allen NE, Key TJ. Re: plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study. J Natl Cancer Inst. 2001;93(8):649–51. https://pubmed.ncbi.nlm.nih.gov/11309444/

947

Conover CA. Discrepancies in insulin-like growth factor signaling? No, not really. Growth Horm IGF Res. 2016;30–31:42–4. https://pubmed.ncbi.nlm.nih.gov/27792888/

948

Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S, Key TJ. The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev. 2002;11(11):1441–8. https://pubmed.ncbi.nlm.nih.gov/12433724/

949

Clemmons DR, Seek MM, Underwood LE. Supplemental essential amino acids augment the somatomedin-C/insulin-like growth factor I response to refeeding after fasting. Metabolism. 1985;34(4):391–5. https://pubmed.ncbi.nlm.nih.gov/3884968/

950

Mariotti F, Gardner CD. Dietary protein and amino acids in vegetarian diets – a review. Nutrients. 2019;11(11):2661. https://pubmed.ncbi.nlm.nih.gov/31690027/

951

Ten Have GAM, Engelen MPKJ, Soeters PB, Deutz NEP. Absence of post-prandial gut anabolism after intake of a low quality protein meal. Clin Nutr. 2012;31(2):273–82. https://pubmed.ncbi.nlm.nih.gov/22001026/

952

Katz DL, Doughty KN, Geagan K, Jenkins DA, Gardner CD. Perspective: the public health case for modernizing the definition of protein quality. Adv Nutr. 2019;10(5):755–64. https://pubmed.ncbi.nlm.nih.gov/31066877/

953

Freda PU, Shen W, Reyes-Vidal CM, et al. Skeletal muscle mass in acromegaly assessed by magnetic resonance imaging and dual-photon x-ray absorptiometry. J Clin Endocrinol Metab. 2009;94(8):2880–6. https://pubmed.ncbi.nlm.nih.gov/19491226/

954

Friedlander AL, Butterfield GE, Moynihan S, et al. One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women. J Clin Endocrinol Metab. 2001;86(4):1496–503. https://pubmed.ncbi.nlm.nih.gov/11297574/

955

Levine ME, Suarez JA, Brandhorst S, et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab. 2014;19(3):407–17. https://pubmed.ncbi.nlm.nih.gov/24606898/

956

Allen NE, Appleby PN, Davey GK, Kaaks R, Rinaldi S, Key TJ. The associations of diet with serum insulin-like growth factor I and its main binding proteins in 292 women meat-eaters, vegetarians, and vegans. Cancer Epidemiol Biomarkers Prev. 2002;11(11):1441–8. https://pubmed.ncbi.nlm.nih.gov/12433724/

957

Crimarco A, Springfield S, Petlura C, et al. A randomized crossover trial on the effect of plant-based compared with animal-based meat on trimethylamine-N-oxide and cardiovascular disease risk factors in generally healthy adults: Study With Appetizing Plantfood – Meat Eating Alternative Trial (SWAP-MEAT). Am J Clin Nutr. 2020;112(5):1188–99. https://pubmed.ncbi.nlm.nih.gov/32780794/

958

Arjmandi BH, Khalil DA, Smith BJ, et al. Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab. 2003;88(3):1048–54. https://pubmed.ncbi.nlm.nih.gov/12629084/

959

Khalil DA, Lucas EA, Juma S, Smith BJ, Payton ME, Arjmandi BH. Soy protein supplementation increases serum insulin-like growth factor-I in young and old men but does not affect markers of bone metabolism. J Nutr. 2002;132(9):2605–8. https://pubmed.ncbi.nlm.nih.gov/12221217/

960

Maskarinec G, Takata Y, Murphy SP, Franke AA, Kaaks R. Insulin-like growth factor-1 and binding protein-3 in a 2-year soya intervention among premenopausal women. Br J Nutr. 2005;94(3):362–7. https://pubmed.ncbi.nlm.nih.gov/16176606/

961

Messina M, Magee P. Does soy protein affect circulating levels of unbound IGF-1? Eur J Nutr. 2018;57(2):423–32. https://pubmed.ncbi.nlm.nih.gov/28434035/

962

Nachvak SM, Moradi S, Anjom-Shoae J, et al. Soy, soy isoflavones, and protein intake in relation to mortality from all causes, cancers, and cardiovascular diseases: a systematic review and dose-response meta-analysis of prospective cohort studies. J Acad Nutr Diet. 2019;119(9):1483–1500.e17. https://pubmed.ncbi.nlm.nih.gov/31278047/

963

Applegate CC, Rowles JL III, Ranard KM, Jeon S, Erdman JW Jr. Soy consumption and the risk of prostate cancer: an updated systematic review and meta-analysis. Nutrients. 2018;10(1):40. https://pubmed.ncbi.nlm.nih.gov/29300347/

964

Willcox DC, Willcox BJ, Todoriki H, Suzuki M. The Okinawan diet: health implications of a low-calorie, nutrient-dense, antioxidant-rich dietary pattern low in glycemic load. J Am Coll Nutr. 2009;28(sup4):500S-16S. https://pubmed.ncbi.nlm.nih.gov/20234038/

965

Lousuebsakul-Matthews V, Thorpe DL, Knutsen R, Beeson WL, Fraser GE, Knutsen SF. Legumes and meat analogues consumption are associated with hip fracture risk independently of meat intake among Caucasian men and women: the Adventist Health Study-2. Public Health Nutr. 2014;17(10):2333–43. https://pubmed.ncbi.nlm.nih.gov/24103482/

966

Mazidi M, Katsiki N, Mikhailidis DP, et al. Lower carbohydrate diets and all-cause and cause-specific mortality: a population-based cohort study and pooling of prospective studies. Eur Heart J. 2019;40(34):2870–9. https://pubmed.ncbi.nlm.nih.gov/31004146/